Lipocine Inc
LPCN
Company Profile
Business description
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
Contact
675 Arapeen Drive
Suite 202
Salt Lake City UT 84108
USAT: +1 801 994-7383
E: mb@lipocine.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
17
Stocks News & Analysis
stocks
Going into earnings, Is Facebook parent Meta a buy, a sell, or fairly valued?
Watching ad demand, AI monetization, and platform usage.
stocks
2 ASX shares to avoid
An investor favourite is among the two shares trading at a significant premium to our fair value.
stocks
Is this ASX miner a bargain after shares plunge?
We think investors may have overreacted to recent news.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,205.50 | 3.10 | -0.04% |
| CAC 40 | 7,513.73 | 84.90 | -1.12% |
| DAX 40 | 18,387.46 | 170.24 | -0.92% |
| Dow JONES (US) | 39,853.87 | 504.22 | -1.25% |
| FTSE 100 | 8,153.69 | 13.68 | -0.17% |
| HKSE | 17,311.05 | 158.31 | -0.91% |
| NASDAQ | 17,342.41 | 654.94 | -3.64% |
| Nikkei 225 | 39,154.85 | 439.54 | -1.11% |
| NZX 50 Index | 12,530.99 | 105.41 | 0.85% |
| S&P 500 | 5,427.13 | 128.61 | -2.31% |
| S&P/ASX 200 | 7,963.70 | 7.40 | -0.09% |
| SSE Composite Index | 2,901.95 | 13.42 | -0.46% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Argosy Minerals Ltd AGY | 0.05 | 0.03 | -39.51% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
| Droneshield Ltd DRO | 1.48 | 0.06 | 3.87% |
| Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -4.08% |
| South32 Ltd S32 | 2.96 | 0.02 | -0.67% |
| Zip Co Ltd ZIP | 1.83 | 0.03 | 1.39% |
| Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
| Worley Ltd WOR | 15.23 | 0.04 | 0.26% |